BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3737641)

  • 21. Corticosterone reversibly alters brain alpha-bungarotoxin binding and nicotine sensitivity.
    Grun EU; Pauly JR; Bullock AE; Collins AC
    Pharmacol Biochem Behav; 1995 Nov; 52(3):629-35. PubMed ID: 8545485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of kinetics of nicotine administration on tolerance development and receptor levels.
    Marks MJ; Stitzel JA; Collins AC
    Pharmacol Biochem Behav; 1987 Jul; 27(3):505-12. PubMed ID: 2821553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cat carotid body chemoreceptor responses before and after nicotine receptor blockade with alpha-bungarotoxin.
    Mulligan E; Lahiri S
    J Auton Nerv Syst; 1987 Jan; 18(1):25-31. PubMed ID: 3819313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diurnal variation in nicotine sensitivity in mice: role of genetic background and melatonin.
    Mexal S; Horton WJ; Crouch EL; Maier SI; Wilkinson AL; Marsolek M; Stitzel JA
    Neuropharmacology; 2012 Nov; 63(6):966-73. PubMed ID: 22820272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo.
    Fu Y; Matta SG; Gao W; Sharp BM
    Neuroscience; 2000; 101(2):369-75. PubMed ID: 11074160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic influences on nicotine responses.
    Marks MJ; Stitzel JA; Collins AC
    Pharmacol Biochem Behav; 1989 Jul; 33(3):667-78. PubMed ID: 2587608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice.
    Robinson SF; Grun EU; Pauly JR; Collins AC
    Pharmacol Biochem Behav; 1996 Jul; 54(3):587-93. PubMed ID: 8743633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for two types of nicotinic receptors in the cat carotid body chemoreceptor cells.
    Obeso A; Gómez-Niño MA; Almaraz L; Dinger B; Fidone S; González C
    Brain Res; 1997 Apr; 754(1-2):298-302. PubMed ID: 9134987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular responses to microinjections of nicotine into the caudal ventrolateral medulla of the rat.
    Aberger K; Chitravanshi VC; Sapru HN
    Brain Res; 2001 Feb; 892(1):138-46. PubMed ID: 11172759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
    Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine.
    Marks MJ; Collins AC
    Pharmacol Biochem Behav; 1985 Feb; 22(2):283-91. PubMed ID: 3983219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine.
    Kempsill FE; Pratt JA
    Br J Pharmacol; 2000 Nov; 131(5):997-1003. PubMed ID: 11053222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nicotine, lobeline, and mecamylamine on sensory gating in the rat.
    Curzon P; Kim DJ; Decker MW
    Pharmacol Biochem Behav; 1994 Dec; 49(4):877-82. PubMed ID: 7886101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
    Pauly JR; Marks MJ; Robinson SF; van de Kamp JL; Collins AC
    J Pharmacol Exp Ther; 1996 Jul; 278(1):361-9. PubMed ID: 8764371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity to the seizure-inducing effects of nicotine is associated with strain-specific variants of the alpha 5 and alpha 7 nicotinic receptor subunit genes.
    Stitzel JA; Blanchette JM; Collins AC
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1104-11. PubMed ID: 9495872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic differences in plasma corticosterone levels in response to nicotine injection.
    Freund RK; Martin BJ; Jungschaffer DA; Ullman EA; Collins AC
    Pharmacol Biochem Behav; 1988 Aug; 30(4):1059-64. PubMed ID: 3227029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety.
    Ouagazzal AM; Kenny PJ; File SE
    Eur J Neurosci; 1999 Nov; 11(11):3957-62. PubMed ID: 10583484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating.
    Radek RJ; Miner HM; Bratcher NA; Decker MW; Gopalakrishnan M; Bitner RS
    Psychopharmacology (Berl); 2006 Jul; 187(1):47-55. PubMed ID: 16767415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma.
    Phillips JM; Ehrlichman RS; Siegel SJ
    Neuroscience; 2007 Feb; 144(4):1314-23. PubMed ID: 17184927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
    Bhat RV; Turner SL; Marks MJ; Collins AC
    J Pharmacol Exp Ther; 1990 Oct; 255(1):187-96. PubMed ID: 2213555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.